- call +1-201-465-4211
- email sales@mrinsights.biz
Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin. It is characterized by presence of considerable number of pimples, whiteheads, blackheads, oily skin, and probable scarring. It generally affects skin with comparatively high number of sweat glands at upper part of chest, back, and face. Acne medications are drugs that are indicated for the treatment of acne. These include several prescription and over-the-counter medicines such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives and many more.
Scope of the Report:
This report studies the Acne Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acne Medicine market by product type and applications/end industries.
North America held the largest share of the market in 2017, followed by Europe. On the other hand, Asia-Pacific is anticipated to dominate the market during the analysis period, owing to high population base, increase in disposable income, and improvement in patient awareness about acne medications.
The global Acne Medicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acne Medicine.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Allergan
Nestle (Galderma)
Johnson & Johnson
Mayne Pharma
Mylan
Pfizer
GlaxoSmithKline
Sun Pharmaceutical
Teva Pharmaceutical
Valeant Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription Medicine
Over-the-counter (OTC) Medicine
Market Segment by Applications, can be divided into
Inflammatory Acne
Non-inflammatory Acne
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Acne Medicine Market Overview
1.1 Product Overview and Scope of Acne Medicine
1.2 Classification of Acne Medicine by Types
1.2.1 Global Acne Medicine Revenue Comparison by Types (2017-2023)
1.2.2 Global Acne Medicine Revenue Market Share by Types in 2017
1.2.3 Prescription Medicine
1.2.4 Over-the-counter (OTC) Medicine
1.3 Global Acne Medicine Market by Application
1.3.1 Global Acne Medicine Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Inflammatory Acne
1.3.3 Non-inflammatory Acne
1.4 Global Acne Medicine Market by Regions
1.4.1 Global Acne Medicine Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Acne Medicine Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Acne Medicine Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acne Medicine Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Acne Medicine Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acne Medicine Status and Prospect (2013-2023)
1.5 Global Market Size of Acne Medicine (2013-2023)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Acne Medicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.2 Nestle (Galderma)
2.2.1 Business Overview
2.2.2 Acne Medicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Nestle (Galderma) Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Acne Medicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mayne Pharma
2.4.1 Business Overview
2.4.2 Acne Medicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mayne Pharma Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Acne Medicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Acne Medicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.2 Acne Medicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sun Pharmaceutical
2.8.1 Business Overview
2.8.2 Acne Medicine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sun Pharmaceutical Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Acne Medicine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
2.10 Valeant Pharmaceuticals
2.10.1 Business Overview
2.10.2 Acne Medicine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Valeant Pharmaceuticals Acne Medicine Revenue, Gross Margin and Market Share (2016-2017)
3 Global Acne Medicine Market Competition, by Players
3.1 Global Acne Medicine Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Acne Medicine Players Market Share
3.2.2 Top 10 Acne Medicine Players Market Share
3.3 Market Competition Trend
4 Global Acne Medicine Market Size by Regions
4.1 Global Acne Medicine Revenue and Market Share by Regions
4.2 North America Acne Medicine Revenue and Growth Rate (2013-2018)
4.3 Europe Acne Medicine Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Acne Medicine Revenue and Growth Rate (2013-2018)
4.5 South America Acne Medicine Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Acne Medicine Revenue and Growth Rate (2013-2018)
5 North America Acne Medicine Revenue by Countries
5.1 North America Acne Medicine Revenue by Countries (2013-2018)
5.2 USA Acne Medicine Revenue and Growth Rate (2013-2018)
5.3 Canada Acne Medicine Revenue and Growth Rate (2013-2018)
5.4 Mexico Acne Medicine Revenue and Growth Rate (2013-2018)
6 Europe Acne Medicine Revenue by Countries
6.1 Europe Acne Medicine Revenue by Countries (2013-2018)
6.2 Germany Acne Medicine Revenue and Growth Rate (2013-2018)
6.3 UK Acne Medicine Revenue and Growth Rate (2013-2018)
6.4 France Acne Medicine Revenue and Growth Rate (2013-2018)
6.5 Russia Acne Medicine Revenue and Growth Rate (2013-2018)
6.6 Italy Acne Medicine Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Acne Medicine Revenue by Countries
7.1 Asia-Pacific Acne Medicine Revenue by Countries (2013-2018)
7.2 China Acne Medicine Revenue and Growth Rate (2013-2018)
7.3 Japan Acne Medicine Revenue and Growth Rate (2013-2018)
7.4 Korea Acne Medicine Revenue and Growth Rate (2013-2018)
7.5 India Acne Medicine Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Acne Medicine Revenue and Growth Rate (2013-2018)
8 South America Acne Medicine Revenue by Countries
8.1 South America Acne Medicine Revenue by Countries (2013-2018)
8.2 Brazil Acne Medicine Revenue and Growth Rate (2013-2018)
8.3 Argentina Acne Medicine Revenue and Growth Rate (2013-2018)
8.4 Colombia Acne Medicine Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Acne Medicine by Countries
9.1 Middle East and Africa Acne Medicine Revenue by Countries (2013-2018)
9.2 Saudi Arabia Acne Medicine Revenue and Growth Rate (2013-2018)
9.3 UAE Acne Medicine Revenue and Growth Rate (2013-2018)
9.4 Egypt Acne Medicine Revenue and Growth Rate (2013-2018)
9.5 Nigeria Acne Medicine Revenue and Growth Rate (2013-2018)
9.6 South Africa Acne Medicine Revenue and Growth Rate (2013-2018)
10 Global Acne Medicine Market Segment by Type
10.1 Global Acne Medicine Revenue and Market Share by Type (2013-2018)
10.2 Global Acne Medicine Market Forecast by Type (2018-2023)
10.3 Prescription Medicine Revenue Growth Rate (2013-2023)
10.4 Over-the-counter (OTC) Medicine Revenue Growth Rate (2013-2023)
11 Global Acne Medicine Market Segment by Application
11.1 Global Acne Medicine Revenue Market Share by Application (2013-2018)
11.2 Acne Medicine Market Forecast by Application (2018-2023)
11.3 Inflammatory Acne Revenue Growth (2013-2018)
11.4 Non-inflammatory Acne Revenue Growth (2013-2018)
12 Global Acne Medicine Market Size Forecast (2018-2023)
12.1 Global Acne Medicine Market Size Forecast (2018-2023)
12.2 Global Acne Medicine Market Forecast by Regions (2018-2023)
12.3 North America Acne Medicine Revenue Market Forecast (2018-2023)
12.4 Europe Acne Medicine Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Acne Medicine Revenue Market Forecast (2018-2023)
12.6 South America Acne Medicine Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Acne Medicine Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Acne Medicine Picture
Table Product Specifications of Acne Medicine
Table Global Acne Medicine and Revenue (Million USD) Market Split by Product Type
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
